Endocrine Abstracts

Hashimoto’s thyroiditis is the most common autoimmune condition, with increasing number of people being diagnosed and experiencing varying ranges of symptomes and intensities. This makes the diagnosis as well as treatment challenging. The benefit of preventive health management strategies has been successfully working for diabetes type 2, where condition is managed through implementation of healthy lifestyle and patient-doctor shared decision making. Health care today is increasingly digital, with millions of patients using health apps to track their symptoms and report to doctor. Health apps can serve as research tools to understand behavioural patterns influencing health outcomes. We have investigated a correlation between the medication type, dosage and adherence to commonly experienced symptoms such as fatigue, focus and weight in different cohorts of people diagnosed with Hashimoto’s. We observed that the increasing doses of levothyroxine do not scale in relieving symptoms experienced by Hashimoto’s patients. Further management might be necessary to relieve from the most common symptoms, such as focus, muscle pain and digestion issues. This is specifically true for patients experiencing digestive problems, which seem to be independent of medication, but can impact and intensify other thyroid-related symptoms. Next, we have investigated whether using medication reminders (alarms) and making peer-reviewed information available to patients via the mHealth app will result in symptom improvement as well as normalizing BMI and will report our findings in detail at the meeting.